Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 173

1.

Neutrophil gelatinase-associated lipocalin, macrophage inhibitory cytokine 1, and carbohydrate antigen 19-9 in pancreatic juice: pathobiologic implications in diagnosing benign and malignant disease of the pancreas.

Kaur S, Baine MJ, Guha S, Ochi N, Chakraborty S, Mallya K, Thomas C, Crook J, Wallace MB, Woodward TA, Jain M, Singh S, Sasson AR, Skinner V, Raimondo M, Batra SK.

Pancreas. 2013 Apr;42(3):494-501. doi: 10.1097/MPA.0b013e31826a8597.

2.

Potentials of plasma NGAL and MIC-1 as biomarker(s) in the diagnosis of lethal pancreatic cancer.

Kaur S, Chakraborty S, Baine MJ, Mallya K, Smith LM, Sasson A, Brand R, Guha S, Jain M, Wittel U, Singh SK, Batra SK.

PLoS One. 2013;8(2):e55171. doi: 10.1371/journal.pone.0055171. Epub 2013 Feb 1.

3.

Elevated levels of neutrophil gelatinase-associated lipocalin in bile from patients with malignant pancreatobiliary disease.

Zabron AA, Horneffer-van der Sluis VM, Wadsworth CA, Laird F, Gierula M, Thillainayagam AV, Vlavianos P, Westaby D, Taylor-Robinson SD, Edwards RJ, Khan SA.

Am J Gastroenterol. 2011 Sep;106(9):1711-7. doi: 10.1038/ajg.2011.187. Epub 2011 Jun 14.

PMID:
21670771
4.

Differentiation of pancreatobiliary cancer from benign biliary strictures using neutrophil gelatinase-associated lipocalin.

Budzynska A, Nowakowska-Dulawa E, Marek T, Boldys H, Nowak A, Hartleb M.

J Physiol Pharmacol. 2013 Feb;64(1):109-14.

5.

Neutrophil Gelatinase-Associated Lipocalin (NGAL) concentration in urine is superior to CA19-9 and Ca 125 in differentiation of pancreatic mass: Preliminary report.

Hogendorf P, Durczyński A, Skulimowski A, Kumor A, Poznańska G, Strzelczyk J.

Cancer Biomark. 2016 Mar 11;16(4):537-43. doi: 10.3233/CBM-160595.

PMID:
27002756
6.

Clinical value of circulating lipocalins and insulin-like growth factor axis in pancreatic cancer diagnosis.

El-Mesallamy HO, Hamdy NM, Zaghloul AS, Sallam AM.

Pancreas. 2013 Jan;42(1):149-54. doi: 10.1097/MPA.0b013e3182550d9d.

PMID:
22617715
7.

Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers.

Koopmann J, Buckhaults P, Brown DA, Zahurak ML, Sato N, Fukushima N, Sokoll LJ, Chan DW, Yeo CJ, Hruban RH, Breit SN, Kinzler KW, Vogelstein B, Goggins M.

Clin Cancer Res. 2004 Apr 1;10(7):2386-92.

8.

Neutrophil gelatinase-associated lipocalin levels during extracorporeal membrane oxygenation in critically ill children with congenital heart disease: preliminary experience.

Ricci Z, Morelli S, Favia I, Garisto C, Brancaccio G, Picardo S.

Pediatr Crit Care Med. 2012 Jan;13(1):e51-4. doi: 10.1097/PCC.0b013e3181fe4717.

PMID:
21057360
9.

Expressions of neutrophil gelatinase-associated lipocalin in gastric cancer: a potential biomarker for prognosis and an ancillary diagnostic test.

Wang HJ, He XJ, Ma YY, Jiang XT, Xia YJ, Ye ZY, Zhao ZS, Tao HQ.

Anat Rec (Hoboken). 2010 Nov;293(11):1855-63. doi: 10.1002/ar.21230.

10.

Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia.

Moniaux N, Chakraborty S, Yalniz M, Gonzalez J, Shostrom VK, Standop J, Lele SM, Ouellette M, Pour PM, Sasson AR, Brand RE, Hollingsworth MA, Jain M, Batra SK.

Br J Cancer. 2008 May 6;98(9):1540-7. doi: 10.1038/sj.bjc.6604329. Epub 2008 Apr 8.

11.

A Combination of MUC5AC and CA19-9 Improves the Diagnosis of Pancreatic Cancer: A Multicenter Study.

Kaur S, Smith LM, Patel A, Menning M, Watley DC, Malik SS, Krishn SR, Mallya K, Aithal A, Sasson AR, Johansson SL, Jain M, Singh S, Guha S, Are C, Raimondo M, Hollingsworth MA, Brand RE, Batra SK.

Am J Gastroenterol. 2017 Jan;112(1):172-183. doi: 10.1038/ajg.2016.482. Epub 2016 Nov 15.

12.

Neutrophil gelatinase-associated lipocalin: a new prognostic marker in stage I colorectal carcinoma?

Barresi V, Di Gregorio C, Reggiani-Bonetti L, Ieni A, Ponz-De Leon M, Barresi G.

Hum Pathol. 2011 Nov;42(11):1720-6. doi: 10.1016/j.humpath.2010.05.031. Epub 2011 Mar 21.

PMID:
21420718
13.

Serum markers in patients with resectable pancreatic adenocarcinoma: macrophage inhibitory cytokine 1 versus CA19-9.

Koopmann J, Rosenzweig CN, Zhang Z, Canto MI, Brown DA, Hunter M, Yeo C, Chan DW, Breit SN, Goggins M.

Clin Cancer Res. 2006 Jan 15;12(2):442-6.

14.

CA19-9 antigen levels can distinguish between benign and malignant pancreaticobiliary disease.

Morris-Stiff G, Teli M, Jardine N, Puntis MC.

Hepatobiliary Pancreat Dis Int. 2009 Dec;8(6):620-6.

PMID:
20007080
15.

Evaluation of circulating ADH and MIC-1 as diagnostic markers in Egyptian patients with pancreatic cancer.

Mohamed AA, Soliman H, Ismail M, Ziada D, Farid TM, Aref AM, Al Daly ME, Abd Elmageed ZY.

Pancreatology. 2015 Jan-Feb;15(1):34-9. doi: 10.1016/j.pan.2014.10.008. Epub 2014 Oct 27.

PMID:
25464937
16.

Neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury--where do we stand today?

Schmidt-Ott KM.

Nephrol Dial Transplant. 2011 Mar;26(3):762-4. doi: 10.1093/ndt/gfr006. Epub 2011 Feb 9. No abstract available.

PMID:
21310736
17.

MUC4-mediated regulation of acute phase protein lipocalin 2 through HER2/AKT/NF-κB signaling in pancreatic cancer.

Kaur S, Sharma N, Krishn SR, Lakshmanan I, Rachagani S, Baine MJ, Smith LM, Lele SM, Sasson AR, Guha S, Mallya K, Anderson JM, Hollingsworth MA, Batra SK.

Clin Cancer Res. 2014 Feb 1;20(3):688-700. doi: 10.1158/1078-0432.CCR-13-2174. Epub 2013 Nov 15.

18.

Expression of neutrophil gelatinase-associated lipocalin in colorectal neoplastic progression: a marker of malignant potential?

McLean MH, Thomson AJ, Murray GI, Fyfe N, Hold GL, El-Omar EM.

Br J Cancer. 2013 Jun 25;108(12):2537-41. doi: 10.1038/bjc.2013.264. Epub 2013 Jun 4.

19.

Whole blood assessment of neutrophil gelatinase-associated lipocalin versus pediatricRIFLE for acute kidney injury diagnosis and prognosis after pediatric cardiac surgery: cross-sectional study*.

Ricci Z, Netto R, Garisto C, Iacoella C, Favia I, Cogo P.

Pediatr Crit Care Med. 2012 Nov;13(6):667-70. doi: 10.1097/PCC.0b013e3182601167.

PMID:
22895007
20.

Elevated serum neutrophil gelatinase-associated lipocalin is an early predictor of severity and outcome in acute pancreatitis.

Chakraborty S, Kaur S, Muddana V, Sharma N, Wittel UA, Papachristou GI, Whitcomb D, Brand RE, Batra SK.

Am J Gastroenterol. 2010 Sep;105(9):2050-9. doi: 10.1038/ajg.2010.23. Epub 2010 Feb 23.

Supplemental Content

Support Center